ROCKET PHARMACEUTICALS, INC. (RCKT) Share-based Payment Arrangement, Expense USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $10.3 M, a 15% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $40.7 M, a 21.1% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $39.4 M, a 27.1% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31 M, a 6.06% increase from 2021.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.2 M, a 57.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $40.7 M $10.3 M +$1.34 M +15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $39.4 M $9.93 M +$237 K +2.45% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $39.2 M $10.3 M +$2.64 M +34.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $36.5 M $10.2 M +$2.88 M +39% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $33.7 M $8.92 M +$2.65 M +42.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $31 M $9.69 M +$2.66 M +37.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $28.4 M $7.68 M +$688 K +9.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $27.7 M $7.37 M +$58 K +0.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $27.6 M $6.27 M -$1.63 M -20.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $29.2 M $7.04 M +$967 K +15.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $28.3 M $6.99 M +$2.94 M +72.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $25.3 M $7.31 M +$2.82 M +62.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $22.5 M $7.9 M +$3.94 M +99.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $18.6 M $6.07 M +$2.71 M +80.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $15.9 M $4.05 M +$1.35 M +50.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $14.5 M $4.49 M +$351 K +8.48% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $14.2 M $3.96 M +$781 K +24.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $13.4 M $3.36 M +$537 K +19% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $12.8 M $2.69 M +$82 K +3.14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $12.8 M $4.14 M +$1.35 M +48.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $11.4 M $3.18 M -$2.2 M -40.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $13.6 M $2.82 M +$2.46 M +684% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $11.1 M $2.61 M +$1.91 M +273% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $9.23 M $2.79 M +$2.63 M +1641% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $6.6 M $5.38 M +$5.28 M +5336% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.32 M $360 K +$2.06 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$744 K $701 K -$105 K -13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$639 K $160 K -$526 K -76.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$113 K $99 K -$387 K -79.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $274 K -$1.7 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 $806 K +$432 K +116% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $686 K +$492 K +254% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $486 K -$464 K -48.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 $374 K Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $194 K Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $950 K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.